Sudden Sensorineural Hearing Loss (SSNHL) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
Sudden sensorineural hearing loss (SSNHL) is a sensorineural hearing loss of 30 decibels or greater over at least three contiguous audiometric frequencies within 72 hours. Most SSNHL cases do not have an identified cause and are classified as idiopathic. Most SSNHL cases have an unknown etiology and are classified as idiopathic. At the same time, the differential diagnosis includes over a hundred potential etiologies, with the most frequent causes being infectious, otologic, traumatic, vascular or hematologic, neoplastic and others. In the United States, the two most common bacterial infections known to cause SSNHL are Lyme disease and syphilis. Chronic manifestations of Lyme disease, including systemic neurologic involvement and asymmetric sensorineural hearing loss, can occur within the first year of infection. An expanding erythematous rash, erythema migrans, is one of Lyme disease's most characteristic early manifestations. SSNHL may also be a manifestation of various systemic autoimmune disorders and thyroid disorders. Many autoimmune diseases, including Cogan's syndrome, systemic lupus erythematosus, temporal arteritis, and Wegener's granulomatosis, have been associated with sudden hearing loss.
·
In the USA, the incidence of Sudden
sensorineural hearing loss (SSNHL) ranges from 0.2 to 0.7 cases per 5000
population.
Thelansis’s “Sudden Sensorineural
Hearing Loss (SSNHL) Market Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Sudden
Sensorineural Hearing Loss (SSNHL) treatment modalities options for eight major
markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Sudden Sensorineural Hearing Loss (SSNHL) across 8 MM market from the centre
of Excellence/ Public/ Private hospitals participated in the study. Insights
around current treatment landscape, epidemiology, clinical characteristics,
future treatment paradigm, and Unmet needs.
Sudden Sensorineural Hearing Loss
(SSNHL) Market
Forecast Patient Based Forecast Model (MS. Excel Based Automated
Dashboard), which Data Inputs with sourcing, Market Event, and Product Event,
Country specific Forecast Model, Market uptake and patient share uptake,
Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario,
Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment